SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?


To: Captain Jack who wrote (1273)2/2/1999 5:13:00 PM
From: Guy Gadois  Read Replies (1) | Respond to of 1510
 
Thanks for the news item this morning! I see IMNR lurched forward 3/8th today. This company has so much promise...lets see if anyone takes notice after the phase III trials with Remune are over.

Don't believe too many brokers follow this stock. If any at all now.
About six months ago Gruntal put out a buy with a target of 24. Stock exploded to 17 or so and then died. Oh, well...lets see what '99 brings.

Thanks again,

jon



To: Captain Jack who wrote (1273)2/7/1999 9:21:00 PM
From: Alex Glavinos  Read Replies (1) | Respond to of 1510
 
Captain Jack, there hasn't been much activity with the biotechs lately. IMNR Thailand trial results are due next month. I found a good site to review IMNR milestones. This thread has been quiet lately. dailydiffs.com